Serum angiopoietin-related growth factor (AGF) levels are elevated in gestational diabetes mellitus and associated with insulin resistance

Ginekologia Polska

Volumn 83, Issue 10, 2012, Pages 749-753

  Abdullah, Boztosun ^a   Deveci, Köksal ^a   Atilgan, Remzi ^b   Kiliçli, Fatih ^a   Söylemez, Melike Sinem ^c  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Angiopoietin related growth factor; ANGPTL6 protein; Diabetes; Gestational; Human

Indexed keywords

EID: 84872588268     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. International Association of Diabetes and Pregnancy Study Groups, Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010, 33, 676- 682.
2. Jovanovic L, Pettitt D. Gestational diabetes mellitus. JAMA. 2001, 286, 2516-2518.
3. Ferrara A, Kahn H, Quesenberry C, [et al.]. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol. 2004, 103, 526-533.
4. Metzger B, Lowe L, Dyer A, [et al.]. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008, 358, 1991-2002.
5. Langer O, Yogev Y, Most O, [et al.]. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005, 192, 989-997.
6. Rosenberg T, Garbers S, Lipkind H, Chiasson M. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am j Public Health. 2005, 95, 1545-1551
7. Ryan E, O'Sullivan M, Skyler J. Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes. 1985, 34, 380-389.
8. Mastrogiannis D, Spiliopoulos M, Mulla W, Homko C. Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy. Curr Diab Rep. 2009, 9, 296-302.
9. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med. 2008, 18, 6-14.
10. Oike Y, Akao M, Yasunaga K, [et al.]. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med. 2005, 11, 400-408.
11. Carpenter M, Coustan D. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982, 144, 768-773.
12. Radikova Z, Koska J, Huckova M [et al.]. Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects. Exp Clin Endocrinol Diabetes. 2006, 114, 249-256.
13. Stepan H, Ebert T, Schrey S, [et al.]. Serum levels of angiopoietin-related growth factor are increased in preeclampsia. Am J Hypertens. 2009, 22, 314-318.
14. Ebert T, Bachmanna A, Lössner U, [et al.]. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism Clinical and Experimental. 2009, 58, 547-551
15. Namkunga J, Kohb SB, Kong ID, [et al.]. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome. Metabolism Clin Exp. 2011, 60, 564-568
16. Metzger B, Coustan D. Summary and recommendations of the Fourth International Workshop Conference on Gestational Diabetes Mellitus: The Organizing Committee. Diabetes Care. 1998, 21, 161-167.